Atropos Health, acclaimed for its Green Button Clinical Informatics Consult Service, is expanding into the life sciences sector. It will utilize its Evidence Platform for various life sciences applications, including AI innovations and evidence generation.
A Life Science Advisory Board is overseeing this expansion with members like Sean Khozin, MD, MPH, and Gerry McDougall. Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health, said that the platform would allow researchers to enhance their evidence-generation capabilities rapidly.
Atropos Health has also launched a specialized version of the “Green Button,” widely used by clinicians across various institutions like Stanford Health Care and Mayo Clinic. This software will help life sciences companies optimize real-world data assets for numerous purposes, including unmet needs and regulatory initiatives.
Atropos Health’s platform offers an opportunity to operate with data behind customers’ firewalls or engage external data via the Atropos Evidence™ Network. This network provides a secure medium to expand information access and study capabilities.
This development follows Atropos Health’s collaborations with Datavant, AWS, and more. The company aims to transform healthcare with relevant, real-world evidence and continues to build the future of evidence-based medicine.
To read more, click here.
[Source: Business Wire, August 24th, 2023]